{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:43:49Z","timestamp":1777934629643,"version":"3.51.4"},"reference-count":47,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2017-1126"],"award-info":[{"award-number":["PICT 2017-1126"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Antineoplastic drug contamination can result in severe health effects for healthcare workers exposed to them. Despite the worldwide growing concern regarding these drugs and sustained monitoring efforts in developed countries, there is almost no data about surface contamination levels in Argentina, in particular, and South America, in general.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Antineoplastic drug contamination was measured in three Argentinean public hospitals (pharmacy and daycare center areas) by surface wiping and liquid chromatography coupled with tandem mass spectrometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and Discussion<\/jats:title>\n                    <jats:p>\n                      Eleven drugs were detected, in 51 of 58 sampled surfaces, in variable concentrations from 0.00064 to 7.3\u2005ng cm\n                      <jats:sup>\u22122<\/jats:sup>\n                      , with cyclophosphamide, gemcitabine, and paclitaxel as the most prevalent drugs. This highly variable antineoplastic distribution reflects differences in facility layout, number of patients, antineoplastic drug use, etc., at each hospital. Values exceeding the 1\u2005ng cm\n                      <jats:sup>\u22122<\/jats:sup>\n                      threshold were detected in 13 surfaces of the two hospitals handling the largest amounts of antineoplastic drugs. The cyclophosphamide 75th percentile averaged 0.030\u2005ng cm\n                      <jats:sup>\u22122<\/jats:sup>\n                      comparable to the high values reported more than 10 years ago for developed countries, emphasizing the potential of reducing antineoplastic contamination by implementing routine monitoring and improved cleaning and handling procedures.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study is the first survey of multi-compound surface antineoplastic contamination in Argentinean (and South American) hospitals, providing a baseline against which future studies can be compared. Widespread antineoplastic contamination has been detected on numerous surfaces, with concentrations surpassing suggested threshold exposure levels (1\u2005ng cm\n                      <jats:sup>\u22121<\/jats:sup>\n                      ) for some surfaces in two of the sampled hospitals.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10781552231188320","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T11:20:44Z","timestamp":1689852044000},"page":"14-23","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Initial assessment of multi-compound antineoplastic drug surface contamination in Argentinean healthcare centers: Insights into occupational exposures in South America"],"prefix":"10.1177","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9017-7931","authenticated-orcid":false,"given":"Eric D","family":"Speranza","sequence":"first","affiliation":[{"name":"Universidad Nacional Arturo Jauretche"},{"name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas, C.A.B.A., Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Jeronimo","sequence":"additional","affiliation":[{"name":"School of Population and Public Health, University of British Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Colombo","sequence":"additional","affiliation":[{"name":"School of Population and Public Health, University of British Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.2174\/1389557054368781"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198511073131901"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.56.6.354"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.shaw.2014.06.001"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03007863"},{"key":"e_1_3_2_7_2","first-page":"51","article-title":"Exposure risk in the handling and administration of chemotherapy agents: A review and synthesis of the literature","volume":"7","author":"Ritchie MA","year":"2000","unstructured":"Ritchie MA, McAdams C, Fritz N. Exposure risk in the handling and administration of chemotherapy agents: A review and synthesis of the literature. Online J Knowl Synth Nurs 2000; 7: 51\u201360.","journal-title":"Online J Knowl Synth Nurs"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e31812dfe1e"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6955-9-15"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.12.030"},{"key":"e_1_3_2_11_2","first-page":"165","volume-title":"Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings","author":"NIOSH","year":"2004","unstructured":"NIOSH. Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, NIOSH Publication, 2004; 165."},{"key":"e_1_3_2_12_2","first-page":"1","article-title":"Standards of practice: Safe handling of cytotoxics","volume":"13","author":"ISOPP","year":"2007","unstructured":"ISOPP. Standards of practice: Safe handling of cytotoxics. J Oncol Pharm Practice 2007; 13: 1\u201381.","journal-title":"J Oncol Pharm Practice"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1310\/hpj4909-811"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp180564"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-015-8868-y"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/15459624.2016.1165912"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/annweh\/wxx070"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155211402106"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijheh.2017.03.005"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155217704990"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155218773862"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/annweh\/wxab013"},{"key":"e_1_3_2_23_2","first-page":"599","article-title":"Environmental toxicants in developing countries","volume":"104","author":"Ostrosky-Wegman P","year":"1996","unstructured":"Ostrosky-Wegman P, Gonsebatt ME. Environmental toxicants in developing countries. Environ Health Perspect 1996; 104: 599\u2013602.","journal-title":"Environ Health Perspect"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/19338244.2016.1222346"},{"key":"e_1_3_2_25_2","unstructured":"Union for International Cancer Control. Addressing the rising burden of cancer in Argentina: Challenges & opportunities. Report UICC Switzerland 2020."},{"key":"e_1_3_2_26_2","unstructured":"AAFA. Preparaci\u00f3n y fraccionamiento de medicamentos parenterales. Report Argentine Association of Hospital Pharmacists Argentina 2007."},{"key":"e_1_3_2_27_2","unstructured":"ANMAT. Farmacopea Argentina. Vol. IV Text 1025. National Health Ministry of Argentina Buenos Aires Argentina 2003."},{"key":"e_1_3_2_28_2","unstructured":"Kohen N Viniegra M. Procedimientos basicos para la preparaci\u00f3n administraci\u00f3n y desecho de drogas citostaticas. Instituto Nacional de C\u00e1ncer Ministerio de Salud Republica Argentina 2011."},{"key":"e_1_3_2_29_2","unstructured":"Kolesnik A Accardi R Rodio J et al. Gu\u00eda para la manipulaci\u00f3n de medicamentos citost\u00e1ticos en establecimientos asistenciales (Oncolog\u00eda). National Ministry of Defense of Argentina NORMA DEF SAN 1090-A Buenos Aires Argentina 2020."},{"key":"e_1_3_2_30_2","unstructured":"SIVER. Sala de situaci\u00f3n del C\u00e1ncer en la Rep\u00fablica Argentina. Argentine National Cancer Institute Buenos Aires Argentina. Report Instituto Nacional del Cancer Argentina 2016."},{"key":"e_1_3_2_31_2","unstructured":"Ballesteros I Abriata MG. Boletin Vigilancia Epidemiologica: An\u00e1lisis de Situaci\u00f3n de Salud por C\u00e1ncer Argentina 2018. Report Argentine National Cancer Institute Argentina 2018."},{"key":"e_1_3_2_32_2","unstructured":"INDEC. La industria farmac\u00e9utica en la Argentina. Informe 8323 Ministry of Public Treasury and Finance Argentina 2016."},{"key":"e_1_3_2_33_2","unstructured":"Bisang R Luzuriaga JP San Martin M. El mercado de los medicamentos en la Argentina. Report Centro de Estudios para el Cambio Estructural Argentina. 2017."},{"key":"e_1_3_2_34_2","unstructured":"INDEC. Industria farmac\u00e9utica en la Argentina. Industria manufacturera vol. 6 no. 32 Ministry of Public Treasury and Finance Argentina 2022."},{"key":"e_1_3_2_35_2","volume-title":"Handling hazardous drugs. Chapter 800","author":"United States Pharmacopeia (USP)","year":"2014","unstructured":"United States Pharmacopeia (USP). Handling hazardous drugs. Chapter 800. Rockville, MD: The United States Pharmacopeial Convention, 2014."},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1080\/15459624.2020.1777296"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155208096904"},{"key":"e_1_3_2_38_2","first-page":"3","article-title":"Environmental contamination with cytostatic drugs: past, present and future","author":"Sessink PJM","year":"2011","unstructured":"Sessink PJM. Environmental contamination with cytostatic drugs: past, present and future. Saf Consid Oncol Pharm Special Edition. Fall 2011; 3: 3\u20135.","journal-title":"Saf Consid Oncol Pharm"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.4212\/cjhp.v68i4.1467"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155216676632"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155221992103"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/annweh\/wxx065"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19148601"},{"key":"e_1_3_2_44_2","first-page":"444","article-title":"Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies\u2014the MEWIP project","volume":"57","author":"Kiffmeyer TK","year":"2013","unstructured":"Kiffmeyer TK, Tuerk J, Hahn M, et al. Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies\u2014the MEWIP project. Ann Occup Hyg 2013; 57: 444\u2013455.","journal-title":"Ann Occup Hyg"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00420-023-01963-y"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-021-17607-y"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2014-000549"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155220907125"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552231188320","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10781552231188320","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552231188320","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:28:46Z","timestamp":1777688926000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10781552231188320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1177\/10781552231188320"],"URL":"https:\/\/doi.org\/10.1177\/10781552231188320","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]}}}